Welcome to our dedicated page for HANOVER INSURANCE GROUP SEC filings (Ticker: THG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HANOVER INSURANCE GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HANOVER INSURANCE GROUP's regulatory disclosures and financial reporting.
Hanover Insurance Group (THG) officer Dennis Francis Kerrigan reported a non‑derivative acquisition on 09/26/2025 of 17.513 shares in the form of restricted stock units (RSUs) granted under the company's 2022 Long‑Term Incentive Plan at a $0 price. The filing shows Mr. Kerrigan is an Executive Vice President and the transaction increases his total beneficial ownership to 10,065.273 shares, which includes 33.525 shares acquired the same day under a dividend reinvestment plan exempt from Rule 16a‑11.
The RSUs relate to dividend equivalent rights tied to RSUs previously granted and will vest on the third anniversary of the original grant date. The form was submitted via a confirming statement filed 09/30/2025.
The Hanover Insurance Group, Inc. entered into an underwriting agreement to sell $500 million aggregate principal amount of its 5.500% Notes due 2035. The offering was underwritten by Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as representatives of the several underwriters. The Notes were registered on Form S-3 and issued under the companys Base Indenture dated April 8, 2016, as supplemented by a Third Supplemental Indenture dated August 21, 2025. U.S. Bank Trust Company National Association (successor in interest to U.S. Bank National Association) is the trustee. Exhibits include the Underwriting Agreement, the Indenture and Third Supplemental Indenture, the form of security certificate, legal opinion and consent from Ropes & Gray LLP, and a company press release.
The Hanover Insurance Group, Inc. filed an S-3ASR registration statement for securities, incorporating prior SEC filings and standard exhibits. The filing lists corporate governance documents including an Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws incorporated by reference, forms for indenture, warrants, preferred stock certificates and depositary/rights agreements, and legal and auditor consents from Ropes & Gray LLP and PricewaterhouseCoopers LLP. The document references provisions that may limit stockholder actions—including supermajority vote thresholds and restrictions on written consents and special meetings—and notes tax treatment language for original issue discount (zero-coupon) debt securities to be detailed in prospectus supplements. The filing includes signature blocks dated August 18, 2025.
The Hanover Insurance Group, Inc. (THG) filed a Form 144 indicating the intent of an insider to sell up to 5,626 common shares on or after 08/01/2025 through Fidelity Brokerage Services on the NYSE. The proposed sale represents roughly 0.016 % of THG’s 35.8 million shares outstanding and carries an aggregate market value of about $946,033.
The shares were acquired via the exercise of stock options granted on 02/28/2020, with cash used to cover the purchase price on the same date as the planned sale (08/01/2025). The filer reported no other THG share sales in the past three months. As required, the filer certifies not to possess undisclosed material adverse information about the company.
While the transaction is modest relative to THG’s float, Form 144 signals potential insider supply entering the market, which some investors may view as a short-term negative sentiment indicator.